SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 239 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,672,413 | +5.0% | 49,030 | +9.8% | 0.16% | -38.8% |
| Q4 2022 | $1,592,523 | +5.4% | 44,646 | +0.0% | 0.26% | +12.7% |
| Q3 2022 | $1,511,000 | -20.8% | 44,634 | -32.3% | 0.23% | +36.3% |
| Q2 2022 | $1,907,000 | +271.0% | 65,943 | +131.0% | 0.17% | +309.8% |
| Q1 2020 | $514,000 | +44.0% | 28,550 | +89.9% | 0.04% | +86.4% |
| Q4 2019 | $357,000 | -82.0% | 15,038 | -84.6% | 0.02% | -86.0% |
| Q2 2016 | $1,988,000 | +33.6% | 97,600 | 0.0% | 0.16% | +68.8% |
| Q1 2016 | $1,488,000 | -2.6% | 97,600 | -14.2% | 0.09% | -55.5% |
| Q4 2015 | $1,528,000 | +11.6% | 113,700 | +16.5% | 0.21% | +574.2% |
| Q3 2015 | $1,369,000 | -17.9% | 97,600 | -0.6% | 0.03% | -29.5% |
| Q2 2015 | $1,667,000 | +189.9% | 98,200 | +106.6% | 0.04% | +214.3% |
| Q1 2015 | $575,000 | +197.9% | 47,541 | +120.7% | 0.01% | +180.0% |
| Q1 2014 | $193,000 | – | 21,539 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 826,488 | $23,918,563 | 3.20% |
| ARMISTICE CAPITAL, LLC | 4,650,000 | $134,571,000 | 1.84% |
| Seaport Global Advisors, LLC | 16,069 | $465,037 | 1.11% |
| Aristotle Capital Boston, LLC | 1,159,828 | $33,565,419 | 1.03% |
| S&T BANK/PA | 189,356 | $5,480 | 1.01% |
| RICE HALL JAMES & ASSOCIATES, LLC | 529,952 | $15,336,811 | 0.89% |
| Bridge City Capital, LLC | 78,675 | $2,276,855 | 0.88% |
| Tributary Capital Management, LLC | 346,261 | $10,020,793 | 0.84% |
| Bruce & Co., Inc. | 82,105 | $2,376,119 | 0.83% |
| Stephens Investment Management Group LLC | 1,904,864 | $55,126,764 | 0.81% |